EXOMIND® + ExoTMS®
A modern TMS option for Major Depressive Disorder.
EXOMIND uses targeted magnetic stimulation to activate brain regions involved in mood regulation. Treatment is non-invasive, requires no anesthesia, and sessions are typically under 30 minutes.
What is TMS?
Transcranial magnetic stimulation (TMS) uses an electromagnetic coil placed against the scalp to deliver magnetic pulses to targeted areas of the brain. It does not involve surgery, anesthesia, or an implanted device. Patients remain awake during treatment and typically return to normal activities afterward.
What makes EXOMIND different?
Modern ExoTMS technology
Built on established TMS principles with a contemporary treatment platform.
Short sessions
Treatment sessions are under 30 minutes.
Reduced visit burden for some patients
Appropriate patients may have treatment plans involving as few as six sessions. Some patients may require additional treatment; the schedule is individualized.
How it works
Step 1
Evaluate
Dr. Griffith reviews diagnosis, prior treatment, medications, safety factors, and goals.
Step 2
Personalize
The treatment area and stimulation settings are determined for you.
Step 3
Treat + reassess
You complete the recommended series while symptoms and response are tracked over time.
What to expect
- You remain awake and seated comfortably.
- The applicator is positioned against the scalp.
- You may feel tapping or pulsing sensations.
- No anesthesia is required.
- Most patients can return to normal daily activities immediately afterward.
TMS can cause side effects. Temporary scalp discomfort or headache can occur, and rare serious risks are reviewed during screening. Dr. Griffith will review contraindications, including relevant implanted metal or electronic devices and seizure risk, before treatment.
Regulatory
FDA-cleared use
EXOMIND is intended for treatment of Major Depressive Disorder (MDD) in adult patients who have failed to achieve satisfactory improvement from prior antidepressant medication in the current episode.
Other psychiatric symptoms or conditions may be discussed as part of your overall care. We do not present anxiety, sleep, trauma, cravings, weight loss, brain fog, OCD, or other conditions as FDA-cleared EXOMIND indications.
Frequently asked questions
You do not need to decide on treatment today.
Start with a private physician-led consultation and find out whether EXOMIND belongs in your treatment plan.